BlockSent: A Multi-Pharma Clinical Trial Informed Consent Solution Based on Blockchain

Presentations

Accelerate Late-Stage R&D

BlockSent: A Multi-Pharma Clinical Trial Informed Consent Solution Based on Blockchain

Presentation by Xavier Brand, Novartis
Published on: October 24, 2020
MMembers Only